Oral Administration of Euglena Gracilis Z Alleviates Constipation and Cardiac Dysfunction in a Mouse Model of Isoproterenol-Induced Heart Failure

• Published in: Circulation Reports 2022/02/10, Vol.4(2), pp.83-91
• Main Authors: Umei, Masahiko, Akazawa, Hiroshi, Saga-Kamo, Akiko, Yagi, Hiroki, Liu, Qing, Matsuoka, Ryo, Kadowaki, Hiroshi, Shindo, Akito, Nakashima, Ayaka, Yasuda, Kosuke, Suzuki, Kengo, Komuro, Issei
• Format: Article
• Language: English
• Subjects: Cardiac dysfunction; Constipation; Euglena; Heart Failure; Isoproterenol; Mouse model; Original article
• ISSN: 2434-0790; 2434-0790
• DOI: 10.1253/circrep.CR-21-0094

Background:Patients with heart failure (HF) often experience gastrointestinal problems such as constipation, diarrhea, and disturbances to drug absorption. In HF, hypoperfusion and congestion cause structural and functional changes in the gut, which, in turn, lead to impaired cardiac function.Euglena gracilisZ (hereafter “Euglena”), calledMidorimushiin Japanese, is a microalga that is used as a food or nutritional supplement. It is unclear whether Euglena is beneficial for bowel habitus and cardiac function in subjects with HF.Methods and Results:We injected C57BL/6 male mice subcutaneously with isoproterenol (ISO) (20 mg/kg/day) for 7 days to examine bowel movement in HF. Euglena was orally administered to mice on anad libitum-feeding to a normal chow containing 2% dietary mixture. ISO induced a decrease in bowel movement and an increase in fecal retention in the cecum, as well as a decrease in left ventricular (LV) contraction. Euglena accelerated intestinal transit, relieved fecal retention, and prevented the alterations in gut pathology in ISO-treated mice. Euglena also suppressed ISO-induced decreases in LV contraction, although it had no significant effect on LV hypertrophy.Conclusions:The results suggested that oral administration of Euglena alleviated constipation and cardiac dysfunction in a mouse model of ISO-induced HF, and highlight the potential clinical benefit of Euglena in patients with HF in preventing constipation and contractile deterioration.